Related Experiment Video

Updated: Jul 5, 2026

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

Future lines of treatment. 1908

W J Tyson

    The Practitioner
    |May 2, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
    08:14

    Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

    Published on: May 4, 2017

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
    08:25

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

    Published on: April 11, 2018

    Related Experiment Videos

    Last Updated: Jul 5, 2026

    Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
    11:31

    Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

    Published on: May 20, 2016

    Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
    08:14

    Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

    Published on: May 4, 2017

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
    08:25

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

    Published on: April 11, 2018

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Improving pain control in diabetic neuropathy.

    The Practitioner·2017

    Tailor management to the patient with fibroids.

    The Practitioner·2017

    Preventing stroke and assessing risk in women.

    The Practitioner·2017

    Early referral improves long-term outcomes in rheumatoid arthritis.

    The Practitioner·2017

    Diagnosing and managing mild cognitive impairment.

    The Practitioner·2017

    Be vigilant for dementia in Parkinson’s disease.

    The Practitioner·2017
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us